Drug Profile
IR 103
Alternative Names: IR-103; REMUNE + Amplivax combination; RemuneX; Second generation HIV vaccine - Immune Response BioPharmaLatest Information Update: 20 Jan 2023
Price :
$50
*
At a glance
- Originator Orchestra Therapeutics
- Developer Immune Response BioPharma; Orchestra Therapeutics
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV-1 infections